UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031169
Receipt number R000035369
Scientific Title Evaluation of sense of commercial eye drops for contact lens wearers
Date of disclosure of the study information 2018/02/07
Last modified on 2018/03/07 18:11:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of sense of commercial eye drops for contact lens wearers

Acronym

Evaluation of sense of commercial eye drops for contact lens wearers

Scientific Title

Evaluation of sense of commercial eye drops for contact lens wearers

Scientific Title:Acronym

Evaluation of sense of commercial eye drops for contact lens wearers

Region

Japan


Condition

Condition

Contact lens wearers

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the refreshing feeling of commercial eye drops for contact lens wearers which have cooling sensation.

Basic objectives2

Others

Basic objectives -Others

None

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Four eye drops will be tested. Instill one drop each to both eyes with wearing contact lenses, and then answer to the questionnaire. (Take interval of 30 minutes for each eye drops)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Four eye drops will be tested for one time each.
(Instill one drop each to both eyes, and test another eye drops after 30 minutes in the same way.)
a) Eye drops P: New Mytear CL Cool - a
b) Eye drops Q: New Mytear CL Cool Hi-a
c) Eye Drops R: New Mytear CL Cool Ice Crush
d) Eye drops S: First Mytear CL-B

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Those who wearing contact lenses.
2) Those who have no disease in the eyes.
3) Those who purchase commercial cool type eye drops for contact lens wearers by themselves.

Key exclusion criteria

1) Those who are not wearing contact lenses.
2) Those who have not purchased commercial eye drops.
3) Those who mainly use non-cool type eye drops for contact lens wearers.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hitosh Adachi

Organization

Senju Pharmaceutical Co., Ltd

Division name

Nonprescription Drug Division

Zip code


Address

2-5-8 Hiranomachi, Chuo-ku, Osaka Japan

TEL

06-6201-9615

Email

hitoshi-adachi@senju.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Nobuyoshi Soma

Organization

Senju Pharmaceutical Co., Ltd

Division name

Nonprescription Drug Division Marketing Third Group

Zip code


Address

2-5-8 Hiranomachi, Chuo-ku, Osaka Japan

TEL

06-6201-9615

Homepage URL


Email

n-souma@senju.co.jp


Sponsor or person

Institute

Senju Pharmaceutical Co., Ltd

Institute

Department

Personal name



Funding Source

Organization

Senju Pharmaceutical Co., Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 02 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 01 Month 29 Day

Date of IRB


Anticipated trial start date

2019 Year 02 Month 05 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 02 Month 06 Day

Last modified on

2018 Year 03 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035369


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name